Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults.
Díez-Domingo J, Tinoco JC, Poder A, Dinleyici EC, Nell H, Salamanca de la Cueva I, Ince T, Moreira ED Jr, Ahmed K, Luz K, Kovshirina Y, Medina Pech CE, Akhund T, Romolini V, Costantini M, Mzolo T, Kunnel B, Lechevin I, Aggravi M, Tiberi P, Narendran K, García-Martínez JA, Basile V, Fragapane E, Lattanzi M, Pellegrini M. Díez-Domingo J, et al. Among authors: aggravi m. Hum Vaccin Immunother. 2022 Dec 31;18(1):1981085. doi: 10.1080/21645515.2021.1981085. Epub 2021 Oct 6. Hum Vaccin Immunother. 2022. PMID: 34614379 Free PMC article. Clinical Trial.
A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind study.
Vandermeulen C, Leroux-Roels I, Vandeleur J, Staniscia T, Girard G, Ferguson M, Icardi G, Schwarz TF, Neville AM, Nolan T, Cinquetti S, Akhund T, Van Huyneghem S, Aggravi M, Kunnel B, de Wergifosse B, Domenico GFD, Costantini M, Vir Singh P, Fragapane E, Lattanzi M, Pellegrini M. Vandermeulen C, et al. Among authors: aggravi m. Vaccine. 2021 Oct 29;39(45):6628-6636. doi: 10.1016/j.vaccine.2021.09.068. Epub 2021 Oct 9. Vaccine. 2021. PMID: 34635373 Free article. Clinical Trial.
Physicochemical and biopharmaceutical characterization of endo-2-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-1H-benz[e]isoindol-1-one (CR3124) a novel potent 5-HT3 receptor antagonist.
Cappelli A, Travagli V, Zanardi I, Anzini M, Giorgi G, Donati A, Aggravi M, Casolaro M, Fresta M, Paccagnini E, Makovec F, Vomero S. Cappelli A, et al. Among authors: aggravi m. J Pharm Sci. 2006 Dec;95(12):2706-21. doi: 10.1002/jps.20705. J Pharm Sci. 2006. PMID: 16924684
PVA/STMP based hydrogels as potential substitutes of human vitreous.
Leone G, Consumi M, Aggravi M, Donati A, Lamponi S, Magnani A. Leone G, et al. Among authors: aggravi m. J Mater Sci Mater Med. 2010 Aug;21(8):2491-500. doi: 10.1007/s10856-010-4092-7. Epub 2010 May 25. J Mater Sci Mater Med. 2010. PMID: 20499140
14 results